“We are very excited to join forces with Neuraxpharm. The team has built one of the most relevant European players in the CNS field.”
Dr. Jörg Rockenhäuser - Partner and Head of DACH at Permira

Neuraxpharm is a specialty pharmaceutical company focused on the treatment of CNS disorders.

The company specialises in the development, manufacture and commercialisation of value-added medicines and healthcare products for those suffering with chronic neurological and psychiatric disorders including epilepsy, Parkinson’s, Alzheimer’s, depression and psychosis.

Neuraxpharm aims to become the leading CNS-focused specialty platform in Europe.